Loading...
XHKG
0314
Market cap138mUSD
Oct 28, Last price  
1.42HKD
1D
4.41%
1Q
5.19%
IPO
-93.00%
Name

Sipai Health Technology Co, Ltd

Chart & performance

D1W1MN
XHKG:0314 chart
P/E
—
P/S
0.46
EPS
—
Vol. 1Y
53.70%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.02b
2,017,384,638
Net income
-121m
-121,050,831
CFO
6m
6,355,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sipai Health Technology Co., Ltd. is a Chinese enterprise specializing in medical technology and health management. Its business operations are diversified across three primary divisions: Specialty Pharmacy, Physician Research Assistance, and Health Insurance Services. The Specialty Pharmacy division manages a network of dedicated pharmacies and is also involved in the distribution of pharmaceutical products to drug manufacturers and other supply chain partners. Through its Physician Research Assistance segment, Sipai Health provides comprehensive site management organization (SMO) support to pharmaceutical firms and clinical research institutions. These services encompass a broad spectrum, including site identification and setup, patient acquisition and oversight, data and document handling, on-site logistical management of drugs and biosamples, and trial conclusion. Additionally, this segment offers specialized image management for clinical studies. The Health Insurance Services division functions as an intermediary, delivering brokerage solutions to various insurance providers. Established in 2014, the company's headquarters are situated in Guangzhou, China.
IPO date
Dec 23, 2022
Employees
Domiciled in
CN
Incorporated in
KY
Legal address
c/o Campbells Corporate Services Limited
Floor 4, Willow House
Cricket Square
Grand Cayman KY1-9010
KY
Headquarters
7/F, Building 3
Xingguangyao Plaza
No. 1888, Caoyang Road
Putuo District
Shanghai, SH 200333
CN
Previous name
Si Pai Health Technology Limited

Valuation

Title
CNY in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT